McCarter & English has announcedthat patent attorney Dr. Steven G. Davis has joined the firm as a partner in the Intellectual Property/Information Technology Practice.
Dr. Davis's practice focuses on patent prosecution, portfolio strategy and management, freedom to operate assessments, infringement analysis, patent issues related to IPOs, and intellectual property licensing. He assists universities, start-ups, and major pharmaceutical corporations with protecting technologies in the areas of chemistry, pharmaceuticals, and biotechnology, with a particular emphasis in organic chemistry. Dr. Davis will advise venture capital investors with due diligence investigations and advising other clients prior to acquiring intellectual property assets.
"I am delighted to be joining McCarter's IP group, which has become the go-to practice in the area with good reason," said Dr. Davis. "The infrastructure of the life sciences team is so strong at every level, from partners to associates and support staff, with solid technical backgrounds as well as legal expertise."
Prior to joining McCarter & English, Dr. Davis practiced patent law for 18 years as a partner at Foley & Lardner LLP and as a principal at Hamilton, Brook, Smith & Reynolds. He also worked as in-house patent counsel for Eli Lilly & Co. Dr. Davis has co-authored eight scientific publications and is a co-inventor on U.S. Patent 5,073,564 covering photo-activated insecticides. After completing graduate school, he worked for five years conducting research in the areas of pesticide chemistry and the preparation of compounds containing stable isotopes.